A federal appeals court temporarily reinstated a nationwide requirement that abortion pills be obtained in person, ...
The first-of-its-kind pilot could lead to speedier regulatory approval of medical drugs and devices and potentially reduce ...
The Food and Drug Administration (FDA) is taking the first steps toward potentially easing access to certain peptide injections that are currently restricted due to safety concerns. The agency on ...
The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its newly approved obesity pill, according to a letter posted on the health regulator's website. The ...
April 14 (Reuters) - The U.S. Food and Drug Administration has asked Eli Lilly (LLY.N), opens new tab for more data on liver injury linked to its newly approved obesity pill, according to a letter ...
FDA required additional post-approval evaluation of myocardial infarction, stroke, and other cardiovascular events because approval-era data were insufficient to fully characterize risk with this new ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29 ...
FDA To Review Whether To Allow More Access To Certain Peptides By HealthDay Staff HealthDay ReporterFRIDAY, April 17, 2026 (HealthDay News) — The U.S. Food and Drug Administration (FDA) will soon ...
In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development. Science and technology editor Eric Smalley interviewed Jeffrey Skolnick, eminent scholar in ...
The Texas Legislature's decision last year to invest $50 million in taxpayer money on a clinical trial for the powerful hallucinogen ibogaine came amid a rising tide of enthusiasm around psychedelics.
New Weight Loss Pill Gets Approval But FDA Seeks More Safety Data By HealthDay Staff HealthDay ReporterWEDNESDAY, April 15, 2026 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results